TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Aspiria AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,827
|
1,818
|
1,556 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
5
|
190
|
107 |
| Total assets |
624
|
861
|
733 |
| Current assets |
619
|
851
|
703 |
| Current liabilities |
377
|
602
|
485 |
| Equity capital |
247
|
259
|
248 |
| - share capital |
51
|
54
|
57 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.6%
|
30.1%
|
33.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
0.3%
|
10.5%
|
6.9% |
| Return on assets (ROA) |
0.8%
|
22.1%
|
14.6% |
| Current ratio |
164.2%
|
141.4%
|
144.9% |
| Return on equity (ROE) |
2.0%
|
73.4%
|
43.1% |
| Change turnover |
125
|
344
|
-674 |
| Change turnover % |
7%
|
23%
|
-30% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.